Similar Items: Magic Mushrooms as Medicine: What the United States Can Learn from Jamaica’s Unregulated Psilocybin Industry as FDA Approval Nears
- Taking a Trip into Nature’s Medicine Cabinet: A Country Comparison of Efforts to Reschedule Psilocybin and MDMA for Therapeutic Use
- The Illusion of Interchangeability: The Benefits and Dangers of Guidance-Plus Rulemaking in the FDA's Biosimilar Approval Process
- Punishment in “Disneyland”: A Magical Review of Singaporean Sentencing Law, Policy & Practice
- The Starving Artist: What The US Can Learn from Dutch Artist-Focused Legislation About Equitable Remuneration for Musical Creators
- FDA's New Approval Plan for COVID-19 Vaccines: An Inquiry of "Benefit" Rather than the Statutory Scope of "Safety, Purity, and Potency"?
- AI Art and U.S. Copyright Decisions: What the U.S. Can Do Differently Than China and the E.U. To Efficiently Promote Balance Between AI Innovation and Copyright Regulation